Lolli, C., Verde, A., Degli Esposti, L., Acciai, V., Brigido, A., Proietti, E., & Scagliarini, S. (2024). Cabozantinib use in second or subsequent line of treatment in renal cell carcinoma: an analysis of Italian administrative databases. Global and Regional Health Technology Assessment, 11(1), 154–160. https://doi.org/10.33393/grhta.2024.2892